Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 12, 2005, Pages 1429-1436

  Sanakkayala, Neelima ^a   Sokolovska, Anna ^a   Gulani, Jatinder ^a   HogenEsch, Harm ^a   Sriranganathan, Nammalwar ^b   Boyle, Stephen M ^b   Schurig, Gerhardt G ^b   Vemulapalli, Ramesh ^a,c  

^a PURDUE UNIVERSITY   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BETA GALACTOSIDASE; BRUCELLA ABORTUS RB51 VACCINE; BRUCELLA VACCINE; INTERLEUKIN 12; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BRUCELLA ABORTUS; BRUCELLA ABORTUS RB51; BRUCELLOSIS; CELL MATURATION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFECT; DRUG SAFETY; ESCHERICHIA COLI; FEMALE; GAMMA IRRADIATION; IMMUNE RESPONSE; INFECTION PREVENTION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RADIATION DOSE; TH1 CELL; VACCINATION;

ANIMALS; BRUCELLA ABORTUS; BRUCELLA VACCINE; BRUCELLOSIS; CYTOKINES; DENDRITIC CELLS; ESCHERICHIA COLI; GAMMA RAYS; GENETIC VECTORS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; RADIATION DOSAGE; TH1 CELLS; VIRUS REPLICATION;

EID: 29144475473     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.12.1429-1436.2005     Document Type: Article

References (32)

1. Agranovich, I., D. E. Scott, D. Terle, K. Lee, and B. Golding. 1999 Down-regulation of Th2 responses by B. abortus, a strong Th1 stimulus, correlates with alterations in the B7.2-CD28 pathway. Infect. Immun. 67:4418-4426.
2. Allen, C. A., L. G. Adams, and T. A. Ficht. 1998. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival. Infect. Immun. 66:1008-1016.
3. Baker, C. N., S. N. Banerjee, and F. C. Tenover. 1994. Evaluation of Alamar colorimetric MIC method for antimicrobial susceptibility testing of gram-negative bacteria. J. Clin. Microbiol. 32:1261-1267.
4. Bandekar, J. R., and D. P. Nerkar. 1987. Antitumor activity of lipopolysaccharide and radio-detoxified lipopolysaccharide of Vibrio parahaemolyticus. Microbiol. Immunol. 31:675-681.
5. Cherwonogrodzky, J. W., G. Duhrav, E. Moreno, and H. Mayer. 1990. Antigens of Brucella, p. 19-64. In K. Nielsen and J. R. Duncan (ed.), Animal brucellosis. CRC Press. Inc., Boca Raton, Fla.
6. Corbel, M. J. 1997. Brucellosis: an overview. Emerg. Infect. Dis. 3:213-221.
7. Frenchick, P. J., R. J. Markham, and A. H. Cochrane. 1985. Inhibition of phagosome-lysosome fusion in macrophages hy soluble extracts of virulent Brucella abortus. Am. J. Vet. Res. 46:332-335.
8. Gavin, M. A., M. J. Gilbert, S. R. Riddell, P. D. Greenberg, and M. J. Bevan. 1993. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J. Immunol. 151:3971-3980.
9. + T-cell depletion. J. Virol. 69:3299-3307.
10. Goldstein, J., T. Hoffman, C. Frasch, E. F. Lizzio, P. R. Beining, D. Hochstein, Y. L. Lee, R. D. Angus, and B. Golding. 1992. Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines. Infect. Immun. 60:1385-1389.
11. He, Y., R. Vemulapalli, A. Zeytun, and G. G. Schurig. 2001. Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect. Immun. 69:5502-5508.
12. Hiramoto, R. M., A. J. Galisteo, N. do Nascimento, and H. F. de Andrade, Jr. 2002. 200 Gy sterilised Toxoplasma gondii tachyzoites maintain metabolic functions and mammalian cell invasion, eliciting cellular immunity and cytokine response similar to natural infection in mice. Vaccine 20:2072-2081.
13. Huang, L. Y., J. Aliberti, C. A. Leifer, D. M. Segal, A. Sher, D. T. Golenbock, and B. Golding. 2003. Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p4() secretion, is Toll-like receptor 2 dependent. J. Immunol. 171:1441-1446.
14. Huang, L. Y., C. Reis e Sousa, Y. Itoh, J. Inman, and D. E. Scott. 2001. IL-12 induction by a TH1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10. J. Immunol. 167:1423-1430.
15. Inaba, K., M. Inaha, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
16. + cell-depleted BALB/c mice. J. Virol. 70:3084-3092.
17. Lin, J., and T. A. Ficht. 1995. Protein synthesis in Brucella abortus induced during macrophage infection. Infect. Immun. 63:1409-1414.
18. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92.
19. McQuiston, J. R., R. Vemulapalli, T. J. Inzana, G. G. Schurig, N. Sriranganathan, U. Fritzinger, T. L. Hadfield, R. A. Warren, Luther E. Lindler, N. Snellings, U. Hoover, S. M. Halling, and S. M. Boyle. 1999. Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence. Infect. Immun. 67:3830-3835.
20. Miller, J. H. 1992. A short course in bacterial genetics: a laboratory manual und handbook for Escherichia coli and related bacteria. Cold Spring Harbor Laboratory. Cold Spring Harbor. N.Y.
21. O'Garra, A., and N. Arai. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10:542-550.
22. Pizarro-Cerda, J., E. Moreno, V. Sanguedolce, J. L. Mege, and J. P. Gorvel. 1998. Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect. Immun. 66:2387-2392.
23. Previte, J. J., Y. Chang, and H. M. el-Bisi. 1967. Detoxification of Salmonella typhimurium lipopolysaccharide by ionizing radiation. J. Bacteriol. 93:1607-1614.
24. Radford, A. J., D. G. MacPhee, and D. C. Reanney. 1983. Preparation of plasmid DNA by gamma-irradiation of recA cells. Plasmid 10:229-302.
25. Schurig, G. G., R. M. Roop II, T. Bagchi, S. M. Boyle, D. Buhrman, and N. Sriranganathan. 1991. Biological properties of RB51: a stable rough strain of Brucella abortus. Vet. Microbiol. 28:171-188.
26. Scott, D. E., I. Agranovich, J. Inman, M. Gober, and B. Golding. 1997. Inhibition of primary and recall allergen-specific T-helper cell type 2-mediated responses by a T-helper cell type 1 stimulus. J. Immunol. 159:107-116.
27. Vemulapalli, R., S. Cravero, C. L. Calvert, T. E. Toth, N. Sriranganathan, S. M. Boyle, O. L. Rossetti, and G. G. Schurig. 2000. Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kDa outer membrane protein of B. abortus. Clin. Diagn. Lab. Immunol. 7:114-118.
28. Vemulapalli, R., A. J. Duncan, S. M. Boyle, N. Sriranganathan, T. E. Toth, and G. G. Schurig. 1998. Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect. Immun. 66:5684-5691.
29. Vemulapalli, R., Y. He, S. M. Boyle, N. Sriranganathan, and G. G. Schurig. 2000. Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1-type immune responses. Infect. Immun. 68:3290-3296.
30. Vemulapalli, R., Y. He, S. Cravero, N. Sriranganathan, S. M. Boyle, and G. G. Schurig. 2000. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect. Immun. 68:3286-3289.
31. Winter, A. J., G. G. Schurig, S. M. Boyle, N. Sriranganathan, J. S. Bevins, F. M. Enright, P. H. Elzer, and J. D. Kopec. 1996. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Am. J. Vet. Res. 57:677-683.
32. + T-cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus. Infect. Immun. 63: 2720-2728.